Avycaz
Payments companies reported to CMS as associated with Avycaz. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Avycaz, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Avycaz
These are the largest totals companies reported as associated with Avycaz. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Javeed Siddiqui | Roseville, CA | Infectious Disease | $99,017.96 |
| Christian Sandrock | Sacramento, CA | Internal Medicine | $96,899.94 |
| Joshua Rosenberg | Brooklyn, NY | Critical Care Medicine (Internal Medicine) | $85,630.81 |
| James Mckinnell | Torrance, CA | Infectious Disease | $82,811.41 |
| Fariborz Rezai | Livingston, NJ | Critical Care Medicine (Internal Medicine) | $50,421.23 |
| George Sakoulas | San Diego, CA | Infectious Disease | $44,681.80 |
| Yoav Golan | Boston, MA | Infectious Disease | $29,363.30 |
| Vipul Ganatra | Phoenix, AZ | Infectious Disease | $28,553.55 |
| Kerry Cleveland | Memphis, TN | Infectious Disease | $22,222.80 |
| William Pace | Southampton, PA | Infectious Disease | $20,129.18 |
Prescribed Avycaz?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.